Gujarat

Candidates after submitting their applications through On-Line shall send photocopies of their all academic/required documents regarding their claims along with print out of On-Line application form within 21 days from the last date of submitting the applications (date 03rd October, 2016 till 5.00 O' Clock) on the working day through registered/Speed Post or Personally in the office of the Commission.

Torrent Pharmaceuticals Limited, is a dominant player in the therapeutic areas of cardiovascular (CV) and central nervous system (CNS) and has achieved significant presence in gastro-intestinal, diabetology, anti-infective and pain management segments. Torrent Pharma’s competitive advantage as a manufacturer stems from its world-class manufacturing facilities. Its manufacturing facilities at Indrad, Gujarat, comply with WHO, cGMP, MHRA and TGA norms and have received ISO 9001, ISO 14001 and OHSAS 18001

Post: QA, QC, TABLET, PACKAGING

Out of all the five senses man is endowed with, “Vision” is unique among them. Eyes are undoubtedly our very windows to this world. Ambiguities in vision is no longer a factor associated with age instead owes its origin to a multitude of ever-changing factors in our milieu which include rising levels of pollution, increased sensitivity causing allergies, infections, etc. eyecare has thus emerged as an issue of concern.  Optho Remedies Pvt. Ltd. is a pharmaceutical company headquartered in Allahabad, U.P. with a stronghold in the Ophthalmic segment, and marketing extent stretching all over the country.

Post : MR/ASM/RSm

National Health Mission (NHM) encompassing two Sub-Missions, National Health Mission (NHM) and National Urban Health Mission (NUHM). It is both flexible and dynamic and is intended to guide States towards ensuring the achievement of universal access to health care through strengthening of health systems, institutions and capabilities.

Post : Pharmacist Cum Data Assistant (AYUSH Pharmasy)

Zydus Hospira Oncology Private Limited (ZHOPL) is a 50%-50% joint venture (JV) company between Zydus Cadila. India and Hospira (a Pfizer company), manufacturing cytotoxic injectable products (Finished Products). With our past success in more than 30 regulatory inspections including USFDA. MHRA, PMDA. Japan etc... we now embark upon a journey of Self Reliant and making ZHOPL, a Centre of Excellence (CoE) for Oncology products.

Sardar Patel University comprises of 25 Postgraduate Departments, a constituent collage, and number of colleges affiliated to it. There are 14 PG Centers in the affiliated Colleges, linstitutions. The teaching programme covered at Postgraduate, Medicine, Homeopathy, Home Science, Law and Education includes Postgraduate Degree Courses, Postgraduate Diploma Courses, Diploma Courses, and Advanced Certificate Courses, Undergraduate Courses are taught in the colleges or institutes affiliated to the University.

{ DOWNLOAD AS PDF }

ABOUT AUTHORS
J A Sathwara¹, A M Bhandari^2
1* Department of Pharmacology, A.R.College of Pharmacy & G.H.Patel Institute of Pharmacy, Anand ,Gujarat
² Department of Clinical Pharmacy, A.R.College of Pharmacy & G.H.Patel Institute of Pharmacy, Anand ,Gujarat
*jignasa.sathwara@gmail.com

ABSTRACT
The development of drugs is costly for the Pharmaceutical companies and without the protection of Intellectual Properties, the formula for the drug can easily be duplicated and can be synthesized at cheaper cost. The U.S. intellectual property laws protect the rights of small inventors and large corporations alike to guarantee “the first to invent” the exclusive right to the patents. To solve the drug price inflation within the U.S., an initiative has been taken that drug patents are different from other innovations. Under the new plan, new drugs would be sold at generic prices upon FDA’s approval. New drugs will no longer be rewarded by net-profit from sales, but instead by Medical Innovation Prize Fund at a level of 0.5% of the gross domestic product, that provide money to developers of new products based upon the actual impact on health outcomes over ten years. Although patents protect the rights of the investors and courage innovations, there are certain ideas that should not been patented. Potentially lifesaving technologies should be separated from other type of innovations, and money making should not be the only inceptive for drug discovery. The number of worldwide who have access to medicines is low, an allowing patents on drugs, although increase the number of advancements in lifesaving technologies; it will decrease the number of people who access to them. International efforts should focus on allocating monetary motivation to provide people to access drugs.